Critical Care Suite with Enteric Tube Positioning AI Algorithm

K253502 · Ge Medical Systems, LLC · QIH · Apr 14, 2026 · Radiology

Device Facts

Record IDK253502
Device NameCritical Care Suite with Enteric Tube Positioning AI Algorithm
ApplicantGe Medical Systems, LLC
Product CodeQIH · Radiology
Decision DateApr 14, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.2050
Device ClassClass 2
AttributesAI/ML, Software as a Medical Device, Pediatric

AI Performance

OutputAlgorithmAcceptanceObservedDev DSDev ReadersTest DSTest Readers
Enteric tube detection and localizationAI deep learning algorithmsSensitivity: 0.992 (0.982, 0.997); Specificity: 0.975 (0.947, 0.991); Mean DICE score: 0.911 (0.912, 0.921); Mean tip error: 1.789 mm (1.222, 2.356); Mean side port error: 2.575 mm (1.731, 3.420)Over 12,000 images from 15 sources located across the United States, Canada, European Union, and India.Ground truth dataset of 954 images from five sites across North America and the United Kingdom.5 (expert annotators)
Enteric tube tip detectionAI deep learning algorithmsSensitivity: 0.957 (0.935, 0.973); Specificity: 0.941 (0.901, 0.968)Over 12,000 images from 15 sources located across the United States, Canada, European Union, and India.Ground truth dataset of 954 images from five sites across North America and the United Kingdom.5 (expert annotators)
Enteric tube side port detectionAI deep learning algorithmsSensitivity: 0.931 (0.904, 0.952); Specificity: 0.859 (0.801, 0.905)Over 12,000 images from 15 sources located across the United States, Canada, European Union, and India.Ground truth dataset of 954 images from five sites across North America and the United Kingdom.5 (expert annotators)
Airway and diaphragm localizationAI deep learning algorithmsMean DICE score (airway): 0.741 (0.730, 0.753); Mean DICE score (diaphragm): 0.821 (0.808, 0.834)Over 12,000 images from 15 sources located across the United States, Canada, European Union, and India.Ground truth dataset of 954 images from five sites across North America and the United Kingdom.5 (expert annotators)

Indications for Use

Critical Care Suite with Enteric Tube Positioning AI Algorithm is intended to provide automated radiological image processing and analysis tools implementing artificial intelligence including nonadaptive machine learning algorithms trained with clinical and/or artificial data

Device Story

Software module for automated analysis of frontal chest and abdominal X-ray images; detects/localizes enteric tubes, tube tips, side ports, diaphragm, and airways. Inputs: digital X-ray images. Processing: AI deep learning algorithms (non-adaptive). Outputs: on-screen image overlays and DICOM tags transmitted to PACS. Used in clinical settings (e.g., mobile X-ray systems like AMX Navigate) by trained healthcare professionals and radiologists. Assists clinicians in assessing enteric tube placement; provides immediate visualization upon acquisition. Benefits: rapid identification of tube position to support clinical decision-making.

Clinical Evidence

Performance evaluated against a ground truth dataset of 954 images (diverse patient ages, multiple vendors, varying quality). Ground truth established by five expert radiologists via double-read and arbitration. Results: Tube detection sensitivity 0.992, specificity 0.975; mean DICE 0.911. Tube tip detection sensitivity 0.957, specificity 0.941. Side port sensitivity 0.931, specificity 0.859. Airway localization mean DICE 0.741; diaphragm localization mean DICE 0.821. Mean localization errors: 1.789 mm (tip), 2.575 mm (side port).

Technological Characteristics

Software-based automated radiological image processing. Utilizes AI deep learning algorithms. Deployed as a self-contained module on computing platforms including PACS, on-premise servers, cloud, or digital projection radiographic systems (e.g., AMX Navigate). Non-adaptive machine learning. DICOM-compliant for image annotation and tag transmission.

Indications for Use

Indicated for adult and pediatric patients. Analyzes frontal chest and abdominal x-ray images to detect and localize nasally or orally inserted enteric tubes, tube tips, and side ports (if present). Also detects and localizes diaphragm and airways (carina with left and right bronchi). Intended for use by licensed qualified healthcare professionals trained in enteric tube placement and radiologists. Not for use in-lieu of full patient evaluation or as sole basis for diagnosis; does not replace professional review of X-ray images.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

Submission Summary (Full Text)

{0} FDA U.S. FOOD & DRUG ADMINISTRATION Ge Medical Systems, LLC Chris Paulik Sr. Regulatory Affairs Manager 3000 N. Grandview Blvd. Waukesha, WI 53188 April 14, 2026 Re: K253502 Trade/Device Name: Critical Care Suite with Enteric Tube Positioning AI Algorithm Regulation Number: 21 CFR 892.2050 Regulation Name: Medical Image Management And Processing System Regulatory Class: Class II Product Code: QIH Dated: October 30, 2025 Received: October 30, 2025 Dear Chris Paulik: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K253502 - Chris Paulik Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13484 clause 8.3 (Nonconforming product), and ISO 13485 clause 8.5 (Corrective and preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical- {2} K253502 - Chris Paulik Page 3 devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, ![img-0.jpeg](img-0.jpeg) Jessica Lamb Assistant Director Imaging Software Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} | Indications for Use | | | | --- | --- | --- | | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K253502 | ? | | Please provide the device trade name(s). | | ? | | Critical Care Suite with Enteric Tube Positioning AI Algorithm | | | | Please provide your Indications for Use below. | | ? | | Critical Care Suite with Enteric Tube AI Algorithm analyzes frontal chest and abdominal x-ray images and produces an on-screen image overlay that detects and localizes an enteric tube that has been inserted nasally or orally, locates the tube tip, and locates the tube side port (if present). It also produces an on- screen image overlay that detects and localizes the diaphragm and the airways (carina with left and right bronchi). This information is also transmitted to the radiologist for review. Intended users include licensed qualified healthcare professional (HCP) who have been trained to independently place and/or assess the placement of enteric tubes inserted nasally or orally and radiologists. Critical Care Suite with the Enteric Tube Positioning AI Algorithm should not be used in-lieu of full patient evaluation or solely relied upon to make or confirm a diagnosis. It is not intended to replace the review of the X-ray image by a qualified healthcare professional. Critical Care Suite with the Enteric Tube Positioning AI algorithm is indicated for both adult and pediatric patients. | | | | Please select the types of uses (select one or both, as applicable). | ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? | {4} GE Healthcare 510(k) Premarket Notification Submission - Critical Care Suite with Enteric Tube Positioning AI Algorithm GE HealthCare # K253502 # 510(k) Summary: In accordance with 21 CFR 807.92 the following summary information is provided: | Date: | April 13, 2026 | | --- | --- | | Owner / Submitter: | GE HealthCare, (GE Medical Systems, LLC) 3000 N. Grandview Blvd Waukesha, WI 53188 USA | | Primary Contact Person: | Chris Paulik Senior Regulatory Affairs Manager GE Healthcare 262-894-5415 Christopher.A.Paulik@gehealthcare.com | | Secondary Contact Person: | Gregory Pessato Regulatory Affairs Director GE Healthcare +33 (6) 34423240 GregoryPessato@gehealthcare.com | | Device Trade Name: | Critical Care Suite with Enteric Tube Positioning AI Algorithm | | Common / Usual Name: | Medical Image Management and Processing System | | Regulation Name: | Medical Image Management and Processing System | | Regulation: | 21 CFR 892.2050 | | Classification: | Class II | | Product Code: | QIH | | Predicate Device: | Critical Care Suite with Endotracheal Tube Positioning AI Algorithm (K211161) Regulation Name: Medical Image Management and Processing System Regulation: 21 CFR 892.2050 Classification: Class II Product Codes: QIH | | Device Description: | Critical Care Suite is a suite of AI algorithms for the automated image analysis of x-rays acquired on a digital x-ray system for the presence of critical findings, quality checks and/or measurements. Critical Care Suite with Enteric Tube Positioning AI Algorithm is a quantification tool that analyses chest and abdominal x-ray images for the presence of an enteric tube that has been inserted either nasally or orally. This algorithm was developed using over 12,000 images from 15 sources located across the United States, Canada, European Union, and India. If an enteric tube is detected, it highlights the tube's location within the image and locates its tip and side port (if present). It then highlights the airways (carina with the left and right bronchi) as well as the diaphragm. | Page 2 of 6 {5} GE Healthcare 510(k) Premarket Notification Submission - Critical Care Suite with Enteric Tube Positioning AI Algorithm GE HealthCare | | The users of this algorithm are those licensed qualified healthcare providers (HCP) that have been trained to independently place and/or assess the placement of an enteric tube and radiologists. The outputs of the proposed algorithm are intended to assist these users in their assessment of the enteric tube placement within pediatric and adult patients. Critical Care Suite with Enteric Tube Positioning AI Algorithm is a software module that can be deployed on several computing platforms such as PACS, On Premise, On Cloud or Digital Projection Radiographic Systems. The AMX Navigate mobile x-ray system was chosen as the initial platform for deployment because enteric tube placement images are almost exclusively acquired on mobile x-ray systems due to the limited mobility of the patients requiring an enteric tube. | | --- | --- | | Intended Use: | Critical Care Suite with Enteric Tube Positioning AI Algorithm is intended to provide automated radiological image processing and analysis tools implementing artificial intelligence including nonadaptive machine learning algorithms trained with clinical and/or artificial data | | Indications for Use: | Critical Care Suite with Enteric Tube AI Algorithm analyzes frontal chest and abdominal x-ray images and produces an on-screen image overlay that detects and localizes an enteric tube that has been inserted nasally or orally, locates the tube tip, and locates the tube side port (if present). It also produces an on-screen image overlay that detects and localizes the diaphragm and the airways (carina with left and right bronchi). This information is also transmitted to the radiologist for review. Intended users include licensed qualified healthcare professional (HCP) who have been trained to independently place and/or assess the placement of enteric tubes inserted nasally or orally and radiologists. Critical Care Suite with the Enteric Tube Positioning AI Algorithm should not be used in-lieu of full patient evaluation or solely relied upon to make or confirm a diagnosis. It is not intended to replace the review of the X-ray image by a qualified healthcare professional. Critical Care Suite with the Enteric Tube Positioning AI algorithm is indicated for both adult and pediatric patients. | | Product Device Comparison | Critical Care Suite with Enteric Tube AI Algorithm | Critical Care Suite with Endotracheal Tube Positioning AI Algorithm (K211161) | | --- | --- | --- | | Device Classification | Automated Radiological Image Processing Software Class II, QIH | Automated Radiological Image Processing Software Class II, QIH | | Targeted clinical condition, anatomy, and imaging modality | Enteric Tube Placement Chest/Lung and Stomach Frontal Chest and Abdominal X-Ray Imaging | Endotracheal Tube Placement Chest/Lung Frontal Chest X-Ray Imaging | {6} GE Healthcare 510(k) Premarket Notification Submission - Critical Care Suite with Enteric Tube Positioning AI Algorithm GE HealthCare | Product Device Comparison | Critical Care Suite with Enteric Tube AI Algorithm | Critical Care Suite with Endotracheal Tube Positioning AI Algorithm (K211161) | | --- | --- | --- | | Algorithm Inferencing Mechanism | AI deep learning algorithms designed to visualize and quantify enteric tube positioning in frontal chest and abdominal x-ray images | AI deep learning algorithms designed to visualize and quantify endotracheal tube positioning in frontal chest x-ray images | | Computational Platform | On-Device computation (integrated onto x-ray system) Critical Care Suite with Enteric Tube Positioning AI Algorithm is designed as a self-contained software module deployable on various computational and imaging system platforms. | On-Device computation (integrated onto x-ray system) Critical Care Suite with Endotracheal Tube Positioning AI Algorithm is designed as a self-contained software module deployable on various computational and imaging system platforms. | | Notification / Visualization Recipient and Timing | Clinical Care Team – Licensed qualified healthcare professionals trained on enteric tube placement – immediately on device upon image acquisition for Enteric Tube Positioning AI Algorithm Radiologist – immediately after images are sent to PACS via secondary capture image and DICOM tag | Clinical Care Team – Licensed qualified healthcare professionals trained on endotracheal tube placement – immediately on device upon image acquisition for Endotracheal Tube Positioning AI Algorithm Radiologist – immediately after images are sent to PACS via secondary capture image and DICOM tag | | Algorithm Outputs | **Visualization** • Enteric tube • Enteric Tube Tip • Enteric Tube Side Port • Diaphragm • Airways (carina with left and right bronchi). **Quantification** • None | **Visualization** • Endotracheal tube • Endotracheal Tube Tip • Carina **Quantification** • Vertical distance between the endotracheal tube tip and carina | | Destination for Viewing Algorithm Results | Image annotation on a secondary DICOM image and a DICOM tag that identifies if an enteric tube was detected within the study. The output can be immediately used to visualize the results on any DICOM destination such as a user’s images storage system (PACS) or the x-ray system. | Image annotation on a secondary DICOM image and a DICOM tag that identifies if an endotracheal tube was detected within the study which includes the vertical distance measurement between the endotracheal tube tip and carina. The output can be immediately used to visualize the results on any DICOM destination such as a user’s images storage system (PACS) or the x-ray system. | Page 4 of 6 {7} GE Healthcare 510(k) Premarket Notification Submission – Critical Care Suite with Enteric Tube Positioning AI Algorithm GE HealthCare | Clinical and Non-Clinical Tests: | Summary of Non-Clinical Tests: | | --- | --- | | The following quality assurance measures were applied to the development of Critical Care Suite with Enteric Tube Positioning AI Algorithm and deployment onto the AMX Navigate system: | | | 1. Risk Analysis | | | 2. Requirements Reviews | | | 3. Design Reviews | | | 4. Testing on unit level (Module verification) | | | 5. Integration testing (System verification) | | | 6. Performance testing (Verification) | | | 7. Safety testing (Verification) | | | 8. Simulated use testing (Validation) | | | Critical Care Suite with Enteric Tube Positioning AI Algorithm specific verification was conducted to demonstrate proper implementation of Critical Care Suite software design requirements. | | | Regression testing on the AMX Navigate functionality was conducted to verify proper integration of Critical Care Suite with Enteric Tube Positioning AI Algorithm into the AMX Navigate software and device. Validation was performed on AMX Navigate with integrated Critical Care Suite with Enteric Tube Positioning AI Algorithm. | | | Design verification and validation testing was performed to confirm that the safety and effectiveness of the device has not been affected. The test plans and results have been executed with acceptable results. | | | Summary of Clinical Tests: | | | The performance of the Enteric Tube Positioning AI Algorithm was tested against a ground truth dataset. The ground truth dataset contained 954 images that were not used in the development of the algorithm from five sites across North America and the United Kingdom to adequately analyze all the primary and secondary endpoints and the results met the defined passing criteria. This dataset included images from both male and female patients that ranged in age from neonates to over 65 years of age. It included both chest and abdominal x-ray images (including babygrams) of varying image quality and difficulty, such as other objects within the image (e.g. breathing tubes). It also included multiple enteric tube types that did or did not include a radiopaque line as well as images acquired on systems from at least eight different vendors. The ground truth was determined by five expert annotators that included both board certified general and pediatric radiologists that conducted two reads on each image with an arbitration process. | | Page 5 of 6 {8} GE Healthcare 510(k) Premarket Notification Submission – Critical Care Suite with Enteric Tube Positioning AI Algorithm GE HealthCare | | The Enteric Tube Positioning AI Algorithm achieved a sensitivity of 0.992 (0.982, 0.997) and a specificity of 0.975 (0.947, 0.991). It also displayed strong localization capabilities with a mean DICE score of 0.911 (0.912, 0.921) for tube localization. For tube tip detection, the algorithm achieved a sensitivity of 0.957 (0.935, 0.973) and a specificity of 0.941 (0.901, 0.968). In assessing side ports, it reached a sensitivity of 0.931 (0.904, 0.952) and a specificity of 0.859 (0.801, 0.905). Additionally, the algorithm delivered mean DICE scores of 0.741 (0.730, 0.753) for airway localization and 0.821 (0.808, 0.834) for diaphragm localization. It also provided precise localization with mean errors of 1.789 mm (1.222, 2.356) for the tube tip and 2.575 mm (1.731, 3.420) for the side port. | | --- | --- | | **Determination of Substantial Equivalence:** | The introduction of Critical Care Suite with Enteric Tube Positioning AI Algorithm does not result in any new potential safety risks, and has the same technological characteristics, and performs as well as the predicate device. After analyzing design verification and validation testing on the bench and in the clinical ground truth study it is the conclusion of GE HealthCare that the Critical Care Suite with Enteric Tube Positioning AI Algorithm software to be as safe, as effective, and performance is substantially equivalent to the predicate device. | Page 6 of 6
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...